The in vitro diagnostics market includes analyzers and reagents used for performing assays in vitro, which can be interpreted as a controlled environment outside of the living organism. This market includes revenues for select segments of immunochemistry, molecular diagnostics, blood donor screening, hemostasis, hematology and point-of-care testing.